Universal Ibogaine Inc. reported earnings results for the first quarter ended October 31, 2023. For the first quarter, the company reported sales was CAD 0.646266 million. Net loss was CAD 0.207849 million compared to CAD 0.841961 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | +50.00% |
|
0.00% | +200.00% |
06-06 | Universal Ibogaine Inc. cancelled the transaction announced on April 22, 2024 | CI |
06-06 | Universal Ibogaine Inc. announced that it has received CAD 0.27 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
+200.00% | 3.48M | |
+25.79% | 89.18B | |
-23.21% | 76.11B | |
+2.32% | 27.11B | |
-10.58% | 17.13B | |
-0.32% | 16.83B | |
+0.52% | 15.4B | |
+77.83% | 13.68B | |
+79.56% | 13.25B | |
-25.61% | 12.83B |
- Stock Market
- Equities
- IBO Stock
- News Universal Ibogaine Inc.
- Universal Ibogaine Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023